NASDAQ:QIPT - Quipt Home Medical Stock Price Target and Predictions

  • Consensus Rating: Buy
  • Consensus Price Target: $10.06
  • Forecasted Upside: 66.87 %
  • Number of Analysts: 8
  • Breakdown:
  • 0 Sell Ratings
  • 0 Hold Ratings
  • 8 Buy Ratings
  • 0 Strong Buy Ratings
$6.03
▼ -0.05 (-0.82%)

This chart shows the closing price for QIPT by one month, three months, or twelve months.

Skip Closing Price Chart
1 month | 3 months | 12 months
Get New Quipt Home Medical Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for QIPT and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for QIPT

Analyst Price Target is $10.06
▲ +66.87% Upside Potential
This price target is based on 8 analysts offering 12 month price targets for Quipt Home Medical in the last 3 months. The average price target is $10.06, with a high forecast of $12.75 and a low forecast of $7.50. The average price target represents a 66.87% upside from the last price of $6.03.

This chart shows the closing price for QIPT for the last year in relation to the current analyst high, average, and low pricetarget.

Read Analyst Price Chart DescriptionSkip Analyst Price Chart

Current Consensus is Buy

The current consensus among 8 investment analysts is to buy stock in Quipt Home Medical.

Past Monthly Recommendations

Move your mouse over past months for details

Read Past Recommendations DescriptionSkip Past Price Target Consensus Chart
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
6/16/2020
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
9/14/2020
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
12/13/2020
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
3/13/2021
  • 0 strong buy ratings
  • 3 buy ratings
  • 0 hold ratings
  • 0 sell ratings
6/11/2021
  • 0 strong buy ratings
  • 4 buy ratings
  • 0 hold ratings
  • 0 sell ratings
9/9/2021
  • 0 strong buy ratings
  • 5 buy ratings
  • 0 hold ratings
  • 0 sell ratings
11/8/2021
  • 0 strong buy ratings
  • 8 buy ratings
  • 0 hold ratings
  • 0 sell ratings
12/8/2021

Latest Recommendations

  • 0 strong buy ratings
  • 8 buy ratings
  • 0 hold ratings
  • 0 sell ratings

Display Ratings By
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
11/24/2021Raymond JamesSet Price TargetOutperform$9.00Low
11/19/2021Canaccord GenuityBoost Price TargetBuyC$10.00 ➝ C$11.00Medium
11/17/2021Raymond JamesSet Price TargetOutperform$9.00Low
11/17/2021Stifel NicolausBoost Price TargetBuyC$12.40 ➝ C$12.75Low
11/9/2021Echelon Wealth PartnersReiterated RatingBuyMedium
10/20/2021BenchmarkInitiated CoverageBuy$7.50High
8/25/2021Raymond JamesReiterated RatingOutperform$9.00Low
7/15/2021Raymond JamesLower Price TargetOutperform$11.25 ➝ $10.00High
6/2/2021Leede Jones GabReiterated RatingBuyLow
6/2/2021Colliers SecuritiesReiterated RatingBuyLow
6/1/2021Beacon SecuritiesReiterated RatingBuyLow
(Data available from 12/9/2016 forward)

News Sentiment Rating

0.43 (Hold)

Our news sentiment rating is based on the average sentiment of articles about this company published in the media in the last 30 days of headlines and can range from 2 (very positive sentiment) to -2 (very negative sentiment).

News Sentiment Over Time

Move your mouse over past months for details

Skip to Current Sentiment Summary
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
5/13/2021
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
6/12/2021
  • 1 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
7/12/2021
  • 2 very positive mentions
  • 4 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
8/11/2021
  • 4 very positive mentions
  • 4 positive mentions
  • 1 negative mentions
  • 0 very negative mentions
9/10/2021
  • 1 very positive mentions
  • 4 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
10/10/2021
  • 0 very positive mentions
  • 2 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
11/9/2021
  • 5 very positive mentions
  • 19 positive mentions
  • 1 negative mentions
  • 0 very negative mentions
12/9/2021

Current Sentiment

  • 5 very positive mentions
  • 19 positive mentions
  • 1 negative mentions
  • 0 very negative mentions

Recent Stories by Sentiment

Very Negative

  • No very negative mentions tracked during this time.
Quipt Home Medical logo
Quipt Home Medical Corp. provides in-home monitoring equipment, supplies, and services for patients in the United States. It offers daily and ambulatory aides; power mobility equipment; BiPAP and CPAP machines, oxygen concentrators, and ventilators; oxygen therapy; sleep apnea and PAP treatment equipment; disease management services; and home ventilator equipment, as well as rents respiratory equipment. The company was formerly known as Protech Home Medical Corp. and changed its name to Quipt Home Medical Corp. in May 2021. Quipt Home Medical Corp. was incorporated in 1993 and is headquartered in Wilder, Kentucky.
Read More

Today's Range

Now: $6.03
Low: $5.97
High: $6.14

50 Day Range

MA: $5.94
Low: $5.18
High: $6.83

52 Week Range

Now: $6.03
Low: $4.40
High: $8.40

Volume

15,313 shs

Average Volume

68,740 shs

Market Capitalization

$201.10 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

N/A

Frequently Asked Questions

What sell-side analysts currently cover shares of Quipt Home Medical?

The following equities research analysts have issued research reports on Quipt Home Medical in the last year: Beacon Securities, Benchmark Co., Canaccord Genuity, Colliers Securities, Echelon Wealth Partners, Leede Jones Gab, Raymond James, Stifel Nicolaus, and Zacks Investment Research.
View the latest analyst ratings for QIPT.

What is the current price target for Quipt Home Medical?

4 Wall Street analysts have set twelve-month price targets for Quipt Home Medical in the last year. Their average twelve-month price target is $10.06, suggesting a possible upside of 66.9%. Stifel Nicolaus has the highest price target set, predicting QIPT will reach $12.75 in the next twelve months. Benchmark Co. has the lowest price target set, forecasting a price of $7.50 for Quipt Home Medical in the next year.
View the latest price targets for QIPT.

What is the current consensus analyst rating for Quipt Home Medical?

Quipt Home Medical currently has 8 buy ratings from Wall Street analysts. The stock has a consensus analyst rating of "Buy." A "buy" rating indicates that analysts believe QIPT will outperform the market and that investors should add to their positions of Quipt Home Medical.
View the latest ratings for QIPT.

How do I contact Quipt Home Medical's investor relations team?

The company's listed phone number is 859-300-6455 and its investor relations email address is [email protected] The official website for Quipt Home Medical is www.protechhomemedical.com.